Heather J, Best K, Oakes T, Gray E, Roe J, Thomas N
Front Immunol. 2016; 6:644.
PMID: 26793190
PMC: 4707277.
DOI: 10.3389/fimmu.2015.00644.
Clark G
Mol Hum Reprod. 2013; 20(3):185-99.
PMID: 24043694
PMC: 3925329.
DOI: 10.1093/molehr/gat064.
Scala E, Abeni D, Pomponi D, Narducci M, Lombardo G, Mari A
Haematologica. 2010; 95(11):1905-12.
PMID: 20663947
PMC: 2966913.
DOI: 10.3324/haematol.2010.026260.
Hirayama K, Ishizu T, Shimohata H, Miyamoto Y, Kakita T, Nagai M
Clin Exp Nephrol. 2009; 14(1):36-42.
PMID: 19809783
DOI: 10.1007/s10157-009-0230-2.
Bostik P, Stephenson S, Lynch R, Cardona A, Ansari A
Virology. 2007; 369(2):324-8.
PMID: 17889219
PMC: 2137892.
DOI: 10.1016/j.virol.2007.07.019.
Distribution and evolution of T-cell receptor Vbeta repertoire on peripheral blood lymphocytes of newborn infants of human immunodeficiency virus (HIV)-infected mothers: differential display on CD4 and CD8 T cells and effect of HIV infection.
Borkowsky W, Chen S, Belitskaya-Levy I
Clin Vaccine Immunol. 2007; 14(9):1215-22.
PMID: 17652526
PMC: 2043316.
DOI: 10.1128/CVI.00092-07.
The role of mutation accumulation in HIV progression.
Galvani A
Proc Biol Sci. 2005; 272(1574):1851-8.
PMID: 16096099
PMC: 1559876.
DOI: 10.1098/rspb.2005.3083.
Proteomic analyser with applications to diagnostics and vaccines.
Hoffmann G
J Theor Biol. 2004; 228(4):459-65.
PMID: 15178195
PMC: 7134612.
DOI: 10.1016/j.jtbi.2004.02.011.
Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load.
Sindhu S, Ahmad R, Morisset R, Ahmad A, Menezes J
J Virol. 2003; 77(3):1848-55.
PMID: 12525619
PMC: 140951.
DOI: 10.1128/jvi.77.3.1848-1855.2003.
T cell receptor usage in patients with non-progressing HIV infection.
Bodman-Smith M, Williams I, Johnstone R, Boylston A, Lydyard P, Zumla A
Clin Exp Immunol. 2002; 130(1):115-20.
PMID: 12296861
PMC: 1906494.
DOI: 10.1046/j.1365-2249.2002.01944.x.
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.
Lawn S, Butera S, Folks T
Clin Microbiol Rev. 2001; 14(4):753-77, table of contents.
PMID: 11585784
PMC: 89002.
DOI: 10.1128/CMR.14.4.753-777.2001.
Early immune responses accompanying human asymptomatic Ebola infections.
Leroy E, Baize S, Debre P, Mavoungou E
Clin Exp Immunol. 2001; 124(3):453-60.
PMID: 11472407
PMC: 1906073.
DOI: 10.1046/j.1365-2249.2001.01517.x.
Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.
Esser M, Bess Jr J, Suryanarayana K, Chertova E, Marti D, Carrington M
J Virol. 2001; 75(3):1152-64.
PMID: 11152488
PMC: 114021.
DOI: 10.1128/JVI.75.3.1152-1164.2001.
Prevotella intermedia stimulates expansion of Vbeta-specific CD4(+) T cells.
Leung K, Torres B
Infect Immun. 2000; 68(9):5420-4.
PMID: 10948175
PMC: 101809.
DOI: 10.1128/IAI.68.9.5420-5424.2000.
Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry.
Saha K, Volsky D, Matczak E
J Virol. 1999; 73(9):7891-8.
PMID: 10438887
PMC: 104324.
DOI: 10.1128/JVI.73.9.7891-7898.1999.
CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virions.
Sylwester A, Grivel J, Fitzgerald W, Rossio J, Lifson J, Margolis L
J Virol. 1998; 72(11):9345-7.
PMID: 9765486
PMC: 110358.
DOI: 10.1128/JVI.72.11.9345-9347.1998.
Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.
Baskar P, Collins G, Pyle R, Nagel J, Dwyer D, Dunston G
Clin Exp Immunol. 1998; 111(2):251-6.
PMID: 9486389
PMC: 1904900.
DOI: 10.1046/j.1365-2249.1998.00488.x.
Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC).
Vingerhoets J, Dohlsten M, Penne G, Colebunders R, Sansom D, Bosmans E
Clin Exp Immunol. 1998; 111(1):12-9.
PMID: 9472656
PMC: 1904857.
DOI: 10.1046/j.1365-2249.1998.00465.x.
Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes.
Herbein G, Van Lint C, Lovett J, Verdin E
J Virol. 1998; 72(1):660-70.
PMID: 9420271
PMC: 109420.
DOI: 10.1128/JVI.72.1.660-670.1998.
Expression of human immunodeficiency virus genes using baculovirus expression system.
Kang C
Mol Biotechnol. 1997; 8(2):173-87.
PMID: 9406188
DOI: 10.1007/BF02752262.